子类别 會議論文/會議摘要 [14/17] 期刊論文 [52/54] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:12(16.90%) 含全文笔数:66(92.96%) 文件下载次数统计 下载大于0次:66(100.00%) 下载大于100次:62(93.94%) 全文下载总次数:27027(0.50%) 最后更新时间: 2024-12-01 10:07 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Survival of advanced/recurrent gast... A phase 1 study of biweekly nab-pac... Analysis of mutation profiles in ex... Germline mutations of homologous re... Risk of type 2 diabetes mellitus an... Imatinib use for gastrointestinal s... PTEN regulates invasiveness in panc... Multi-kinase inhibitors for the tre... Improved survival with neoadjuvant ... Mitochondrial phosphoenolpyruvate c...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-50 / 71. (共2页) 1 2 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-07-11	Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study	BMC Cancer. 2024 Jul 11;24:Article number 828.
2024-04-27	Analysis of mutation profiles in extranodal NK/T-cell lymphoma: Clinical and prognostic correlations	Annals of Hematology. 2024 Apr 27;Article in Press.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2023-10	Risk of type 2 diabetes mellitus and hyperlipidemia in patients with chronic myeloid leukemia initiating tyrosine kinase inhibitors: A nationwide cohort study	Pharmacoepidemiology and Drug Safety. 2023 Oct;32(Suppl. S1):575.
2023-01	Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway	Cancer Medicine. 2023 Jan;12(2):1588-1601.
2022-12-28	Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan	Scientific Reports. 2022 Dec 28;12:Article number 22492.
2022-11-06	PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation	Journal of Biomedical Science. 2022 Nov 06;29:Article number 92.
2022-09	Multi-kinase inhibitors for the treatment of asymptomatic radioactive Iodine-refractory differentiated thyroid cancer: Global non-interventional study (RIFTOS MKI)	Thyroid. 2022 Sep;32(9):1059-1068.
2022-07	Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience	Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-05-15	Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience	American Journal of Cancer Research. 2022 May 15;12(5):2189-2202.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-11-30	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Scientific Reports. 2021 Nov 30;11:Article number 23142.
2021-11-12	The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience	Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
2021-09	Anaplastic thyroid cancer successfully treated with radiation and immunotherapy: A case report	AACE Clinical Case Reports. 2021 Sep;7(5):299-302.
2021-07-20	Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: A nationwide population-based study	European Journal of Preventive Cardiology. 2021 Jul 20;29(9):1312-1321.
2021-07-15	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Scientific Reports. 2021 Jul 15;11:Article number 14567.
2021-05	Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia	Cancer Medicine. 2021 May;10(9):2946-2955.
2021-04-12	An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan	Scientific Reports. 2021 Apr 12;11:Article number 7881.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-03	Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-kappa B/IL-6/ROS signaling	Journal of Experimental and Clinical Cancer Research. 2021 Mar;40:Article number 95.
2021-02	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling	Cancer Science. 2021 Feb;112(Suppl. 1):776.
2021-01	Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan	Journal of the Formosan Medical Association. 2021 Jan;120(1,Pt 1):189-195.
2021-01	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2021 Jan;112(1):243-253.
2020-11-13	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]	Scientific Reports. 2020 Nov 13;10:Article number 20199.
2020-07-01	A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue	Haematologica. 2020 Jul 1;105(7):e349-e354.
2020-05-26	Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan	Journal of Biomedical Science. 2020 May 26;27:Article number 69.
2020-05-04	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort	Scientific Reports. 2020 May 4;10:Article number 7420.
2020-05	An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas	Oncologist. 2020 May;25(5):e782-e788.
2019-12	Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia	Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-10	The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan	Cancer Epidemiology, Biomarkers and Prevention. 2019 Oct;28(10):1694-1703.
2019-09-10	Environmental risk factors of pancreatic cancer	Journal of Clinical Medicine. 2019 Sep 10;8(9):Article number 1427.
2019-04-10	Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants	Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957.
2018-12	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-12	The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan	Cancer Science. 2018 Dec;109(Suppl. 2):1437.
2018-11	The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan	Cancer Medicine. 2018 Nov;7(11):5775-5788.
2018-08-24	BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor	Cancer Science. 2018 Nov;109(11):3591-3601.
2018-08	Stem cell transplantation for T-cell lymphomas in Taiwan	Bone Marrow Transplantation. 2018 Aug;53(8):993-1000.
2018-01	The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors	Cancer Science. 2018 Jan;109(Suppl. 1):466.
2017-10-09	Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors	Oncotarget. 2017 Oct 09;8(61):103613-103625.
2017-09-16	The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors	Oncotarget. 2017 Sep 16;8(58):98068-98083.
2017-09	A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients	Scientific Reports. 2017 Sep;7:Article number 11253.
2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
2017-02	The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)	Journal of Pathology. 2017 Feb;241(3):420-433.
2016-12	Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST	Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P.
2016-10	BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia	Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
2016-10	CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma	Annals of Oncology. 2016 Oct;27(Suppl. 6):Meeting Abstract 933P.
2016-08-31	The oncometabolite R-2-hydroxyglutarate activates NF-kappa B-dependent tumor-promoting stromal niche for acute myeloid leukemia cells	Scientific Reports. 2016 Aug 31;6:Article number 32428.
2016-05	Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma	Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e19024.

显示项目1-50 / 71. (共2页) 1 2 > >> 每页显示[10|25|50]项目